Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine administration methods to prevent propofol injection pain
ChiCTR2100047682Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine in propofol injection site pain (PISP) (3 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Incidence of injection pain. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
propofol injection site pain (PISP)
Beyond the preview
Go deeper on ChiCTR2100047682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047682.